Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multicompartment Models: Overview01:14

Multicompartment Models: Overview

234
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
234
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.0K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

134
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
134
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

120
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
120

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PeptideSGCL: Structure-Enhanced Graph-Transformer Encoding and Dual-Level Contrastive Learning for Peptide Property Prediction.

ACS synthetic biology·2026
Same author

Integrating multi-type features and knowledge graph for graded prediction of drug-induced liver injury in humans.

PLoS computational biology·2026
Same author

DDI-MMAF: Multi-modal affine fusion of visual and semantic representations for anticancer drug synergy prediction.

European journal of medicinal chemistry·2026
Same author

Development and validation of a dual-attention deep learning prediction model for noninvasive differentiation of pulmonary invasive mucinous adenocarcinoma from inflammatory pulmonary nodules.

Translational lung cancer research·2026
Same author

CMA-Nano: A DNA Methylation Detection Method for Nanopore Sequencing Data Based on a Cross-Modal Attention Mechanism.

ACS omega·2026
Same author

An Explainable Deep Learning Framework Integrating DNA Sequence and Transcription Initiation Signals for Gene Expression Prediction.

ACS synthetic biology·2026

Related Experiment Video

Updated: Aug 29, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.6K

A multi-label learning model for predicting drug-induced pathology in multi-organ based on toxicogenomics data.

Ran Su1, Haitang Yang1, Leyi Wei2

  • 1School of Computer Science and Technology, College of Intelligence and Computing, Tianjin University, Tianjin, China.

Plos Computational Biology
|September 7, 2022
PubMed
Summary

A new multi-label learning model, Att-RethinkNet, accurately predicts drug-induced pathological findings in the liver and kidney. This approach enhances early toxicity assessment in drug development by considering multiple toxicities simultaneously.

More Related Videos

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.3K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.1K

Related Experiment Videos

Last Updated: Aug 29, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.6K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.3K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.1K

Area of Science:

  • Toxicogenomics
  • Computational Toxicology
  • Drug Development

Background:

  • Drug-induced toxicity is a major cause of drug withdrawal and necessitates early identification during development.
  • Current methods often focus on single organs or binary toxicity, limiting comprehensive assessment.
  • Detailed pathological findings are crucial for accurate toxicity evaluation.

Purpose of the Study:

  • To develop a novel multi-label learning model, Att-RethinkNet, for predicting drug-induced pathological findings in the liver and kidney.
  • To improve the accuracy and reliability of early-stage toxicity prediction using toxicogenomics data.
  • To create a more comprehensive and generalized model applicable to multiple organs and factors like dose and administration time.

Main Methods:

  • Proposed Att-RethinkNet, a multi-label learning model incorporating a memory structure and attention mechanism.
  • Utilized toxicogenomics data for predicting pathological findings.
  • The model considers compound type, dose, and administration time for enhanced generalization.
  • Enabled simultaneous prediction of multiple pathological findings.

Main Results:

  • Att-RethinkNet demonstrated competitive performance compared to state-of-the-art methods.
  • The model accurately predicts potential hepatotoxicity and nephrotoxicity.
  • Achieved more reliable predictions of multiple pathological findings concurrently.

Conclusions:

  • Att-RethinkNet offers a significant advancement in predicting drug-induced hepatotoxicity and nephrotoxicity.
  • The model's ability to predict multiple pathologies simultaneously enhances early drug safety assessment.
  • This approach provides a more comprehensive and reliable tool for toxicogenomics-based drug development.